ArticleMolecular cancer therapeutics2023

Anticancer Efficacy of KRASG12C Inhibitors Is Potentiated by PAK4 Inhibitor KPT9274 in Preclinical Models of KRASG12C-Mutant Pancreatic and Lung Cancers.

Husain Yar Khan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.